AstraZeneca

AstraZeneca

Develops and commercializes prescription medicines

About AstraZeneca

Simplify's Rating
Why AstraZeneca is rated
A
Rated A+ on Competitive Edge
Rated A on Growth Potential
Rated B on Rating Differentiation

Industries

Biotechnology

Healthcare

Company Size

10,001+

Company Stage

IPO

Headquarters

Cambridge, United Kingdom

Founded

1913

Overview

AstraZeneca focuses on discovering, developing, and selling prescription medicines. The company specializes in three main areas: Oncology, which deals with cancer treatment; Cardiovascular, Renal & Metabolism, which addresses heart, kidney, and metabolic diseases; and Respiratory & Immunology, which targets lung and immune system diseases. Their products are developed through extensive research and development, followed by clinical trials and regulatory approvals before reaching the market. AstraZeneca distinguishes itself from competitors by investing heavily in scientific research and forming strategic partnerships to enhance drug discovery. Their goal is to advance healthcare by creating effective treatments for serious diseases and collaborating with other organizations to improve their research capabilities.

Simplify Jobs

Simplify's Take

What believers are saying

  • Recent EU approval of Imfinzi for lung cancer boosts AstraZeneca's oncology portfolio.
  • Enhertu's EU approval strengthens AstraZeneca's position in breast cancer treatment.
  • AI-driven drug discovery could enhance AstraZeneca's R&D efficiency.

What critics are saying

  • Increased competition in oncology may impact AstraZeneca's market share.
  • Patent expirations, like Symbicort, could lead to revenue loss.
  • Biosimilars threaten AstraZeneca's revenue from biologic drugs.

What makes AstraZeneca unique

  • AstraZeneca excels in oncology, cardiovascular, and respiratory therapeutic areas.
  • The A.Catalyst Network fosters global collaboration and innovation in healthcare.
  • Open Innovation program accelerates drug discovery through shared compounds and technologies.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$3509.6M

Above

Industry Average

Funded Over

2 Rounds

Post IPO Debt funding comparison data is currently unavailable. We're working to provide this information soon!
Post IPO Debt Funding Comparison
Coming Soon

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Flexible Work Hours

Company News

Europawire
Apr 8th, 2025
AstraZeneca Unveils Breakthrough Data on Vaccines and Antibody Therapies for Infections

AstraZeneca unveils breakthrough data on vaccines and antibody therapies for infections.

Delcade
Apr 4th, 2025
Foreign investment in France: Key trends, legal considerations (2024)

AstraZeneca invested €365 million in expanding its production lines in Dunkirk.

Cision
Apr 4th, 2025
Imfinzi Approved In Eu For Aegean

04 April 2025 Imfinzi-based perioperative regimen approved in the EU for resectable non-small cell lung cancer  Approval based on AEGEAN Phase III trial results which showed a 32% reduction in the risk of recurrence, progression or death vs. neoadjuvant chemotherapy alone AstraZeneca's Imfinzi (durvalumab) in combination with chemotherapy has been approved in the European Union (EU) for the treatment of adults with resectable non-small cell lung cancer (NSCLC) at high risk of recurrence and no epidermal growth factor receptor (EGFR) mutations or anaplastic lymphoma kinase (ALK)

Cision
Apr 4th, 2025
Enhertu Approved In Eu In Post-Et Breast Cancer

Enhertu approved in EU in post-ET breast cancer

Cision
Mar 31st, 2025
Imfinzi Approved In The Us For Bladder Cancer

Imfinzi approved in the US for bladder cancer

Recently Posted Jobs

Sign up to get curated job recommendations

Associate Director Manufacturing - Night Shift

Buxton, UK

Senior Counsel - Biopharmaceuticals Business

Wilmington, DE, USA

Senior Scientist - Flow Cytometry

$108.5k - $162.7k/yr

Gaithersburg, MD, USA

See All Jobs

AstraZeneca is Hiring for 528 Jobs on Simplify!

Find jobs on Simplify and start your career today

💡
We update AstraZeneca's jobs every few hours, so check again soon! Browse all jobs →

People Also Viewed

Discover companies similar to AstraZeneca

Abzena

Abzena

Babraham, United Kingdom

Amgen

Amgen

Thousand Oaks, California

argenx

argenx

Ghent, Belgium

Senior Counsel - Biopharmaceuticals Business

Wilmington, DE, USA

Senior Scientist - Flow Cytometry

$108.5k - $162.7k/yr

Gaithersburg, MD, USA

See All Jobs

AstraZeneca is Hiring for 528 Jobs on Simplify!

Find jobs on Simplify and start your career today

💡
We update AstraZeneca's jobs every few hours, so check again soon! Browse all jobs →

People Also Viewed

Discover companies similar to AstraZeneca

Abzena

Abzena

Babraham, United Kingdom

Amgen

Amgen

Thousand Oaks, California

argenx

argenx

Ghent, Belgium